Gapping up
In reaction to earnings/guidance:
- MX +5.4%, OTIS +1.6%, QSR +1.2%, HSBC +0.6%
Select metals/mining stocks trading higher:
- GDX +1.2%, GOLD +1%, NEM +0.9%, RIO +0.7%, FCX +0.6%, .
Select oil/gas related names showing strength:
- HAL +0.9%, XLE +0.7%, SLB +0.7%, BP +0.7%, USO +0.6%, XOM +0.6%, OIH +0.5%, RDS.A +0.5%, .
Other news:
- PAE +67.8% (enters into agreement to be acquired by Amentum for $1.9 bln)
- PHUN +22.3% (continued volatility)
- BRPM +18.8% (FaZe Clan to become a publicly listed company through merger with B. Riley Principal 150 Merger Corp)
- PYPL +5.6% (In response to market rumors regarding a potential acquisition of Pinterest by PayPal (PYPL), PayPal stated that it is not pursuing an acquisition of Pinterest at this time)
- APEN +5.4% (MERIT-Trial meets its primary endpoints for safety and efficacy)
- DWAC +5.2% (continued volatility)
- AUPH +4.8% (report that Bristol-Myers Squibb has expressed interest in acquiring
- AUPH, according to Bloomberg)
- LEV +4.5% (received a conditional purchase order for 1,000 all-electric LionC school buses from Student Transportation of Canada)
- ALKS +3.4% (FDA grants Fast Track designation to nemvaleukin alfa (nemvaleukin) for the treatment of platinum-resistant ovarian cancer)
- HUT +3.1% (provides third site status update)
- BHIL +2.8% (files for 89,628,274 share common stock offering by selling shareholders)
- TCRR +1.9% (announces clinical trial collaboration agreement with Bristol Myers Squibb (BMY) to evaluate gavo-cel in combination with Opdivo and Yervoy)
- MTDR +1.3% (revises dividend policy; doubles quarterly dividend)
- OWLT +1.3% (suspends certain Smart Sock shipments as it relates to recent FDA Warning Letter)
- DRIO +1.1% (files for $200 mln common stock offering; contract with a U.S. National Employer to provide its full multi-condition suite digital therapeutic solutions)
- CWEN +1% (announces sale of its thermal business to KKR)
Analyst comments:
- FIVN +1.8% (upgraded to Overweight from Sector Weight at KeyBanc Capital Markets)
- KNX +1.8% (upgraded to Buy from Neutral at UBS)